Best Small Interfering RNA for amyloid neuropathies, familial
2 Small Interfering RNA drugs used for amyloid neuropathies, familial, ranked by our independent rating. Compare them with all treatments for amyloid neuropathies, familial or the full Small Interfering RNA class. Not medical advice — always consult a professional.
Quick answer: Of the 2 small interfering rna drugs we rate for amyloid neuropathies, familial, none are yet flagged as generics in our price data, and most are injectable. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for amyloid neuropathies, familial; the right choice depends on your situation, so confirm it with your prescriber.
Other drug classes for amyloid neuropathies, familial
Top small interfering rna for amyloid neuropathies, familial: 1. Amvuttra · 2. Onpattro
| # | Drug | Rating | Type | Form | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|
| 1 | Not yet rated | Prescription | Injectable | No data | — | View → | |
| 2 | Not yet rated | Prescription | Injectable | No data | — | View → |
Full ranking · 2 drugs
amvuttra
PrescriptionFDA-sourced
Amvuttra (Vutrisiran Sodium) is a small interfering rna used to treat Polyneuropathies, Familial Amyloid Neuropathies.
Price varies
onpattro
PrescriptionFDA-sourced
Onpattro (Patisiran Sodium) is a small interfering rna used to treat Familial Amyloid Neuropathies.
Price varies
Frequently asked
- What is the best small interfering rna for amyloid neuropathies, familial?
- Ratings are based on FDA regulatory recall-safety data — always consult a professional.
- Which small interfering rna drugs treat amyloid neuropathies, familial?
- pharmaranks lists 2 Small Interfering RNA products used for amyloid neuropathies, familial, per NIH RxClass drug-classification data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.